is the generic ingredient in one branded drug marketed by Otsuka Pharm Co Ltd
, and is included in four NDAs. There are eighteen patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.
This ingredient has one hundred and one patent family members
in forty countries.
There are thirty-six drug master file entries
for aripiprazole. Fifteen suppliers
are listed for this compound. There are eight tentative approvals for this compound.